0001192482-20-000586.txt : 20200630 0001192482-20-000586.hdr.sgml : 20200630 20200630170022 ACCESSION NUMBER: 0001192482-20-000586 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200626 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEN-MAIMON CAROLE CENTRAL INDEX KEY: 0001529611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 201002915 MAIL ADDRESS: STREET 1: C/O IMPAX LABORATORIES, INC. STREET 2: 30831 HUNTWOOD AVENUE CITY: HAYWARD STATE: CA ZIP: 94544 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-06-26 0001374690 Larimar Therapeutics, Inc. LRMR 0001529611 BEN-MAIMON CAROLE C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506 BALA CYNWYD PA 19004 1 1 0 0 President and CEO Common Stock 2020-06-26 4 J 0 25083 0 A 25083 D Pro rata distribution from Chondrial Therapeutics Holdings, LLC ("Holdings") to its members, for no consideration. The reporting person is a member of the board of managers and President and Chief Executive Officer of Holdings. /s/ Jennifer Johansson, Attorney-in-fact 2020-06-30